Tags

Type your tag names separated by a space and hit enter

Mortality from cancer in patients with rheumatoid arthritis.
Scand J Rheumatol. 1995; 24(2):76-8.SJ

Abstract

Data in nationwide Finnish registers were used to study the relationship between rheumatoid arthritis (RA) and site-specific cancers as a cause of death. The study included in all 1,666 subjects who had died in 1989 and who were entitled, under the nationwide sickness insurance scheme, to specially reimbursed medication because of RA. There were 277 deaths from malignancies. The proportion of such deaths in relation to all deaths declined with the duration of RA (p < 0.05). There was an excess of hematopoietic malignancies, particularly in males (p < 0.05). Deaths due to these malignancies, in relation to all cancer deaths, accumulated in long-lasting RA (p < 0.05). This suggests that hematopoietic malignancies arise as a complication of either RA or its treatment and to some degree argues against the notion of a shared etiological agent for these diseases.

Authors+Show Affiliations

Rheumatism Foundation Hospital, Heinola, Finland.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

7747147

Citation

Myllykangas-Luosujärvi, R, et al. "Mortality From Cancer in Patients With Rheumatoid Arthritis." Scandinavian Journal of Rheumatology, vol. 24, no. 2, 1995, pp. 76-8.
Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol. 1995;24(2):76-8.
Myllykangas-Luosujärvi, R., Aho, K., & Isomäki, H. (1995). Mortality from cancer in patients with rheumatoid arthritis. Scandinavian Journal of Rheumatology, 24(2), 76-8.
Myllykangas-Luosujärvi R, Aho K, Isomäki H. Mortality From Cancer in Patients With Rheumatoid Arthritis. Scand J Rheumatol. 1995;24(2):76-8. PubMed PMID: 7747147.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mortality from cancer in patients with rheumatoid arthritis. AU - Myllykangas-Luosujärvi,R, AU - Aho,K, AU - Isomäki,H, PY - 1995/1/1/pubmed PY - 1995/1/1/medline PY - 1995/1/1/entrez SP - 76 EP - 8 JF - Scandinavian journal of rheumatology JO - Scand J Rheumatol VL - 24 IS - 2 N2 - Data in nationwide Finnish registers were used to study the relationship between rheumatoid arthritis (RA) and site-specific cancers as a cause of death. The study included in all 1,666 subjects who had died in 1989 and who were entitled, under the nationwide sickness insurance scheme, to specially reimbursed medication because of RA. There were 277 deaths from malignancies. The proportion of such deaths in relation to all deaths declined with the duration of RA (p < 0.05). There was an excess of hematopoietic malignancies, particularly in males (p < 0.05). Deaths due to these malignancies, in relation to all cancer deaths, accumulated in long-lasting RA (p < 0.05). This suggests that hematopoietic malignancies arise as a complication of either RA or its treatment and to some degree argues against the notion of a shared etiological agent for these diseases. SN - 0300-9742 UR - https://www.unboundmedicine.com/medline/citation/7747147/Mortality_from_cancer_in_patients_with_rheumatoid_arthritis_ L2 - https://www.tandfonline.com/doi/full/10.3109/03009749509099288 DB - PRIME DP - Unbound Medicine ER -